Support expanded research for treatments and care for DIPG pediatric cancer.

Debbie Dingell · Michigan · Democratic

policy impact 2.00 specificity 4.00 extraction confidence 98%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

introduced a resolution honoring May 17 as Diffuse Intrinsic Pontine Glioma (DIPG) Awareness Day to support expanded research for treatments and care for DIPG

Dingell backed a resolution promoting more research into DIPG treatment and care.

Latest News | Congresswoman Debbie Dingell
primary · press_release · model gpt-5.4-mini

U.S. Representatives Debbie Dingell (D-MI-06), David Joyce (R-OH-14), and Michael McCaul (R-TX-10), introduced a resolution honoring May 17 as Diffuse Intrinsic Pontine Glioma (DIPG) Awareness Day to support expanded research for treatments and care for DIPG, a deadly form of pediatric cancer.

Resolution supporting expanded DIPG research and care.

News List | Congresswoman Debbie Dingell
primary · other · model gpt-5.4-mini

It also included two bills that I lead – the Give Kids a Chance Act to expand research into childhood cancer and the Dr. Lorna Breen Health Care Provider Protection Act to prevent suicide and reduce burnout among health care professionals.

Dingell highlighted inclusion of her childhood cancer bill to expand pediatric cancer research.

Dingell Health Priorities Included in HHS Funding Bill | Congresswoman Debbie Dingell
primary · press_release · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

Mrs. Dingell submitted H. Res. 1295. The resolution says the House supports expanded research to better understand DIPG, develop effective treatments, and provide comprehensive care for children with DIPG and their families.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Dingell sponsored a 2026 DIPG Awareness Day resolution with the claim's exact substance: expanded DIPG research, treatments, and comprehensive care. It was referred to Energy and Commerce, so this proves concrete support, not final passage of that resolution.

delivered same_term A for effort

H. Res. 1295 (IH) - Expressing support for the designation of May 17, 2026, as DIPG Awareness Day
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

Public Law 119-75 includes Subtitle A, the Mikaela Naylon Give Kids a Chance Act. It expands FDA authority for molecularly targeted pediatric cancer investigations and amends the Program for Pediatric Studies of Drugs to authorize $25,000,000 for each of fiscal years 2026 through 2028.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The enacted 2026 appropriations law delivered broader pediatric cancer research and treatment-development provisions, including pediatric cancer study authority and dedicated pediatric drug-study funding. This is not DIPG-specific, but it materially advances the pediatric cancer research goal Dingell supported.

delivered same_term A for effort

Public Law 119-75 - Consolidated Appropriations Act, 2026
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): delivered. same_term

Dingell fulfilled the promise in federal office by sponsoring H. Res. 1295 in 2026, which directly supported expanded DIPG research, development of effective treatments, and comprehensive care for affected children and families. The resolution itself had not passed, but the promise was framed as support, and her sponsorship is direct candidate action in the same term. The broader 2026 pediatric cancer provisions also advance the research and treatment-development goal, though they are not DIPG-specific and the evidence does not show Dingell as a principal driver of that law.

provider codex_cli · model gpt-5.5 · confidence 90%